1. Home
  2. LPCN vs OM Comparison

LPCN vs OM Comparison

Compare LPCN & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • OM
  • Stock Information
  • Founded
  • LPCN 1997
  • OM 2003
  • Country
  • LPCN United States
  • OM United States
  • Employees
  • LPCN N/A
  • OM N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • LPCN Health Care
  • OM Health Care
  • Exchange
  • LPCN Nasdaq
  • OM Nasdaq
  • Market Cap
  • LPCN 36.8M
  • OM 44.0M
  • IPO Year
  • LPCN N/A
  • OM 2020
  • Fundamental
  • Price
  • LPCN $4.87
  • OM $1.14
  • Analyst Decision
  • LPCN Strong Buy
  • OM Buy
  • Analyst Count
  • LPCN 1
  • OM 4
  • Target Price
  • LPCN $10.00
  • OM $4.38
  • AVG Volume (30 Days)
  • LPCN 33.5K
  • OM 809.6K
  • Earning Date
  • LPCN 11-07-2024
  • OM 02-19-2025
  • Dividend Yield
  • LPCN N/A
  • OM N/A
  • EPS Growth
  • LPCN N/A
  • OM N/A
  • EPS
  • LPCN N/A
  • OM N/A
  • Revenue
  • LPCN $7,922,926.00
  • OM $114,729,000.00
  • Revenue This Year
  • LPCN N/A
  • OM N/A
  • Revenue Next Year
  • LPCN N/A
  • OM $10.83
  • P/E Ratio
  • LPCN N/A
  • OM N/A
  • Revenue Growth
  • LPCN N/A
  • OM N/A
  • 52 Week Low
  • LPCN $2.44
  • OM $0.44
  • 52 Week High
  • LPCN $11.79
  • OM $5.88
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 47.54
  • OM 59.79
  • Support Level
  • LPCN $4.68
  • OM $0.96
  • Resistance Level
  • LPCN $5.28
  • OM $1.23
  • Average True Range (ATR)
  • LPCN 0.36
  • OM 0.16
  • MACD
  • LPCN -0.01
  • OM -0.02
  • Stochastic Oscillator
  • LPCN 44.44
  • OM 46.53

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.

About OM Outset Medical Inc.

Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.

Share on Social Networks: